← Evidence map

ArticleAnnals of the rheumatic diseases2016

Comparing the immunogenicity of the etanercept biosimilar SB4 with the innovator etanercept: another consideration.

Lisa Marshall et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2016

2017

this papercites it

Comparing the immunogenicity of the etanercept biosimilar SB4 with the innovator etanercept: another consideration. | OpenQuestion